Patients with homozygous c.985A > G mutations consistently present with MCAD activity below 2.5%, while heterozygous or mild MCADD patients may range between 5.7 and 13.9% of normal activity, defined as 2.78 nmol/(min •mg protein).45 This evidence concerns the gene ACADM and medium chain acyl-CoA dehydrogenase deficiency.